Company ProtoKinetix, Incorporated Other OTC

Equities

PKTX

US7437221002

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Inactive Instrument

ProtoKinetix, Incorporated is a research and development stage biotechnology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Companyâs anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. In a clinical setting, AAGP is showing its ability to protect cells from inflammation, repair and replace damaged cells and improve cell survivability over time. The Company has not developed a commercially viable product and has not generated any revenue.

Managers	Title	Age	Since
Clarence Smith CEO	Chief Executive Officer	60	14-05-31
Michael Guzzetta DFI	Director of Finance/CFO	66	17-11-13
Victoria Bantz LAW	General Counsel	-	-

Members of the board	Title	Age	Since
Clarence Smith CEO	Chief Executive Officer	60	14-05-31
Edward McDonough BRD	Director/Board Member	71	15-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	346,713,485	208,325,955 ( 60.09 %)	0	60.09 %

Name	Equities	%	Valuation
Clarence Smith 22.25 %	77,137,093	22.25 %	2 M $
Alexandra Blake Smith 7.990 %	27,700,776	7.990 %	554 016 $
John & Edith Smith 6.766 %	23,458,709	6.766 %	469 174 $
Lachlan Young 2.890 %	10,021,250	2.890 %	200 425 $
Michael Guzzetta 0.2124 %	736,369	0.2124 %	14 727 $
United Bank (Virginia) 0.0146 %	50,600	0.0146 %	1 012 $
Williams Jones Wealth Management LLC 0.005768 %	20,000	0.005768 %	400 $
Edward McDonough 0.000000 %	0	0.000000 %	- $

Protokinetix, Inc.

109 West Main Street

44618, Dalton

http://www.protokinetix.com

address ProtoKinetix, Incorporated(PKTX)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research